Clinical Trial Update: A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a proof-of-concept study to assess local delivery and efficacy of Nanocort for atherosclerosis in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Nanocort

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Atherosclerosis | Phase 1, Phase 2 | Status: UNKNOWN